Skip to main content
. 2019 Aug 8;5(9):1304–1309. doi: 10.1001/jamaoncol.2019.1856

Figure 2. Kaplan-Meier Plots of Distant Recurrence-Free Interval .

Figure 2.

Kaplan-Meier analyses of distant recurrence-free survival interval by Stockholm Tamoxifen (STO-3) trial arm (tamoxifen treated vs untreated arm) for patients with (A) luminal A and (B) luminal B tumor subtypes. The P value is based on a 2-sided log-rank test. DRFI indicates distant recurrence-free interval.